Cargando…

Diagnostic performance evaluation of post-operative serum calcitonin (CT) levels as a factor for good prognosis in medullary thyroid carcinoma (MTC)

Detalles Bibliográficos
Autores principales:	Gąsior-Perczak, Danuta, Kowalska, Aldona, Pałyga, Iwona, Słuszniak, Anna, Mężyk, Ryszard, Góźdź, Stanisław
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3618122/ http://dx.doi.org/10.1186/1756-6614-6-S2-A17

Ejemplares similares

The Cut-Off Level of Recombinant Human TSH-Stimulated Thyroglobulin in the Follow-Up of Patients with Differentiated Thyroid Cancer
por: Kowalska, Aldona, et al.
Publicado: (2015)

Variation of the epidemiological structure of thyroid cancer between year 2000 and 2012
por: Kowalska, Aldona, et al.
Publicado: (2013)

Immune Profiling of Medullary Thyroid Cancer—An Opportunity for Immunotherapy
por: Hińcza-Nowak, Kinga, et al.
Publicado: (2021)

Delayed risk stratification system in pT1aN0/Nx DTC patients treated without radioactive iodine
por: Gąsior-Perczak, Danuta, et al.
Publicado: (2017)

CD276 as a Candidate Target for Immunotherapy in Medullary Thyroid Cancer
por: Hińcza-Nowak, Kinga, et al.
Publicado: (2023)

The p.G534E variant of HABP2 is not associated with sporadic papillary thyroid carcinoma in a Polish population
por: Kowalik, Artur, et al.
Publicado: (2017)

The Delayed Risk Stratification System in the Risk of Differentiated Thyroid Cancer Recurrence
por: Kowalska, Aldona, et al.
Publicado: (2016)

Coexisting Germline CHEK2 and Somatic BRAF(V600E) Mutations in Papillary Thyroid Cancer and Their Association with Clinicopathological Features and Disease Course
por: Gąsior-Perczak, Danuta, et al.
Publicado: (2019)

Immunohistochemistry cannot replace DNA analysis for evaluation of BRAF V600E mutations in papillary thyroid carcinoma
por: Szymonek, Monika, et al.
Publicado: (2017)

The impact of BMI on clinical progress, response to treatment, and disease course in patients with differentiated thyroid cancer
por: Gąsior-Perczak, Danuta, et al.
Publicado: (2018)

Histopathology and immunohistochemistry as prognostic factors for poorly differentiated thyroid cancer in a series of Polish patients
por: Walczyk, Agnieszka, et al.
Publicado: (2020)

Evaluation of ultrasound-guided fine needle aspiration biopsy (USG-FNAB) of thyroid nodules: 12 years of accepted diagnostic algorithm in Holycross Cancer Centre (HCC) in Kielce
por: Sygut, Jacek, et al.
Publicado: (2013)

Effectiveness analysis of papillary thyroid carcinoma (PTC) diagnostics in Holycross Cancer Centre (HCC) in Kielce according to fine needle aspiration biopsy quality assurance program in pathology department between years 2001 and 2012
por: Sygut, Jacek, et al.
Publicado: (2013)

Evaluation of molecular diagnostic approaches for the detection of BRAF p.V600E mutations in papillary thyroid cancer: Clinical implications
por: Kowalik, Artur, et al.
Publicado: (2017)

Is Male Sex A Prognostic Factor in Papillary Thyroid Cancer?
por: Gajowiec, Aleksandra, et al.
Publicado: (2021)

Does the TT Variant of the rs966423 Polymorphism in DIRC3 Affect the Stage and Clinical Course of Papillary Thyroid Cancer?
por: Hińcza, Kinga, et al.
Publicado: (2020)

Incidence of the CHEK2 Germline Mutation and Its Impact on Clinicopathological Features, Treatment Responses, and Disease Course in Patients with Papillary Thyroid Carcinoma
por: Gąsior-Perczak, Danuta, et al.
Publicado: (2021)

Prevalence of macroprolactinaemia in regularly menstruating women with non-toxic goitre or autoimmune thyroid disease
por: Lewandowski, Krzysztof C, et al.
Publicado: (2012)

RET gene mutations spectrum in patients with medullary thyroid carcinoma (MTC) from Great Poland region
por: Kaczmarek-Ryś, Marta, et al.
Publicado: (2015)

Medullary thyroid carcinoma (MTC): unusual metastatic sites
por: Kazakou, Paraskevi, et al.
Publicado: (2021)

Papillary Thyroid Cancer in a Struma Ovarii in a 17-Year-Old Nulliparous Patient: A Case Report
por: Gonet, Agnieszka, et al.
Publicado: (2020)

Preoperative Identification of Medullary Thyroid Carcinoma (MTC): Clinical Validation of the Afirma MTC RNA-Sequencing Classifier
por: Randolph, Gregory W., et al.
Publicado: (2022)

Serum calcitonin negative Medullary thyroid carcinoma
por: Sand, Michael, et al.
Publicado: (2006)

Calcitonin receptor expression in medullary thyroid carcinoma
por: Cappagli, Virginia, et al.
Publicado: (2017)

Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a problematic entity
por: Zajkowska, Klaudia, et al.
Publicado: (2020)

Oncologic outcomes of calcitonin-negative medullary thyroid carcinoma
por: Yue, Wenliang, et al.
Publicado: (2022)

Picture of thyroid cancer in 2012
por: Kowalska, Aldona
Publicado: (2013)

Comparing the effectiveness of stimulation using rhTSH and thyroid hormone withdrawal in the treatment of thyroid cancer
por: Kowalska, Aldona
Publicado: (2015)

Aurora kinases are expressed in medullary thyroid carcinoma (MTC) and their inhibition suppresses in vitro growth and tumorigenicity of the MTC derived cell line TT
por: Baldini, Enke, et al.
Publicado: (2011)

Epidemiology of Simultaneous Medullary and Papillary Thyroid Carcinomas (MTC/PTC): An Italian Multicenter Study
por: Appetecchia, Marialuisa, et al.
Publicado: (2019)

Serum calcitonin estimation in medullary thyroid cancer: basal or stimulated levels?
por: Daumerie, Chantal, et al.
Publicado: (2013)

The Difficulty of Post-Operative Surveillance of Calcitonin Negative Medullary Thyroid Cancer
por: Skutnik, Emily, et al.
Publicado: (2021)

Medullary carcinoma of the thyroid: an update
por: Alevizaki, Maria
Publicado: (2013)

Current Knowledge of Germline Genetic Risk Factors for the Development of Non-Medullary Thyroid Cancer
por: Hińcza, Kinga, et al.
Publicado: (2019)

Effective Preoperative Plasmapheresis Treatment of Severe Hyperthyroidism in a Patient with Giant Toxic Nodular Goiter and Methimazole-Induced Agranulocytosis
por: Barwinek, Katarzyna, et al.
Publicado: (2020)

The Role of (18)F-FDOPA PET/CT in Recurrent Medullary Thyroid Cancer Patients with Elevated Serum Calcitonin Levels
por: Araz, Mine, et al.
Publicado: (2023)

Radiomics Features of Different Sizes of Medullary Thyroid Carcinoma (MTC) and Papillary Thyroid Carcinoma (PTC) Tumors: A Comparative Study
por: Zhao, Ling, et al.
Publicado: (2022)

Calcitonin estimation in patients with nodular goiter and its significance for early detection of MTC: european comments to the guidelines of the American Thyroid Association
por: Elisei, Rossella, et al.
Publicado: (2013)

Medullary thyroid carcinoma and duodenal calcitonin-secreting neuroendocrine tumour: more than coincidence?
por: Huguet, I, et al.
Publicado: (2013)

False positive results using calcitonin as a screening method for medullary thyroid carcinoma
por: Batista, Rafael Loch, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_egnfdatqrql3a4qu534om9gnku